Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
|Articles|January 2, 2018
- Pharmaceutical Technology-01-02-2018
- Volume 42
- Issue 1
Planetary Mixer for Mixing and Dispersion
Ross, Charles & Son’s four-gallon model PDDM-4 planetary dual disperser is suited for vacuum operation, mixing thick slurries and highly-filled pastes. Ross, Charles & Son’s four-gallon model PDDM-4 planetary dual disperser is suited for vacuum operation, mixing thick slurries and highly-filled pastes.
The four-gallon model PDDM-4 planetary dual disperser from Ross, Charles & Son is equipped with two high-viscosity blades and two high-speed dispersers. All four agitators rotate on their own axes while orbiting the vessel, ensuring rapid powder wet-out and deagglomeration.
The mixer is suited for vacuum operation, mixing thick slurries and highly-filled pastes, and includes a jacketed mix vessel. According to the company, the mixer delivers improved dispersion and uniformity throughout a viscosity range up to around 2 million centipoise.
Articles in this issue
over 8 years ago
Pharma Equipment Gets Smartover 8 years ago
Selecting and Installing Peristaltic Pump Tubingover 8 years ago
Boosting Functionality of Container Closuresover 8 years ago
Pharma Braces Itself for Post-Brexit Regulatory Changesover 8 years ago
Tackling the Opioid Crisis with Abuse-Deterrent Formulationsover 8 years ago
Elucidating Parenteral Packaging Requirements for Future Drugsover 8 years ago
In-Line Force Analysis During Vial Fillingover 8 years ago
Glass or Plastic—A Question of Useover 8 years ago
Additional Size for Quaternary Diaphragm PumpsRelated to this article
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.